In the fourth of our series of posts for Stand Up To Cancer, we focus on a clinical trial that's finding faulty genes to improve breast cancer treatment.
New research points to a possible way to help personalise treatment for a type of childhood cancer.
An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.
Scientists have revealed how a genetic switch involved in the packaging of DNA may be key to a cancer cell’s ability to keep growing.
Bowel bacteria, drugs targeting cancers’ metabolic weaknesses and DNA ‘signatures’ – the brightest new ideas in cancer research
What do you get when you combine scientists, a ‘Dragon’s Den’-style pitch, and £200,000 to fund cancer research?
Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.
Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.
Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.